Literature DB >> 20214487

Physician estimate of antiretroviral adherence in India: poor correlation with patient self-report and viral load.

Louise Walshe1, D G Saple, S H Mehta, B Shah, R C Bollinger, A Gupta.   

Abstract

Adherence to antiretroviral therapy (ART) is critical in maintaining viral suppression and minimizing resistance in HIV-infected patients. We compared physician estimates of their patients' ART adherence with participant's self-reported adherence to determine patient-provider agreement and identify correlates of discordance in three private clinics in Mumbai, India. Between December 2004 and April 2005, 277 persons receiving ART at three private clinics in Mumbai, India, were interviewed regarding adherence to ART using the Adult AIDS Clinical Trials Group questionnaire. Physicians were also asked to assess their patients' adherence. Quantitative HIV-1 RNA level was determined for 200 participants. Agreement between provider estimate of adherence and participant self-report was low, kappa = 0.058 (95% confidence interval [CI] 0.011-0126). Of 200 participants whose viral load was obtained, viral suppression was associated with participant self-reported adherence (odds ratio [OR] 3.08; 95% CI 1.65-5.74; p < 0.05), but not with provider estimated adherence (OR 1.2; 95% CI 0.67-2.14; p = 0.54). Cost of ART was positively associated with physician underestimation of participant adherence and older age was negatively associated. No independent correlates of physician overestimation of participant adherence were found. There was poor agreement between physician estimate of adherence and patient self-report. Providers should avoid using their own assessment of patient ART adherence. Instead, providers should rely on effective and validated measures, especially when viral load or drug level monitoring are not readily available.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20214487      PMCID: PMC2864050          DOI: 10.1089/apc.2009.0208

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  22 in total

1.  Measuring HIV treatment adherence in clinical practice.

Authors:  F M Hecht
Journal:  AIDS Clin Care       Date:  1998-08

Review 2.  Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.

Authors:  Jane M Simoni; Ann E Kurth; Cynthia R Pearson; David W Pantalone; Joseph O Merrill; Pamela A Frick
Journal:  AIDS Behav       Date:  2006-05

Review 3.  Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.

Authors:  Edward J Mills; Jean B Nachega; Iain Buchan; James Orbinski; Amir Attaran; Sonal Singh; Beth Rachlis; Ping Wu; Curtis Cooper; Lehana Thabane; Kumanan Wilson; Gordon H Guyatt; David R Bangsberg
Journal:  JAMA       Date:  2006-08-09       Impact factor: 56.272

4.  Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.

Authors:  D L Paterson; S Swindells; J Mohr; M Brester; E N Vergis; C Squier; M M Wagener; N Singh
Journal:  Ann Intern Med       Date:  2000-07-04       Impact factor: 25.391

5.  Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India.

Authors:  Bijal Shah; Louise Walshe; Dattary G Saple; Shruti H Mehta; Jeetender P Ramnani; R D Kharkar; Robert C Bollinger; Amita Gupta
Journal:  Clin Infect Dis       Date:  2007-03-22       Impact factor: 9.079

6.  Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance.

Authors:  Rita Murri; Adriana Ammassari; Maria Paola Trotta; Andrea De Luca; Sara Melzi; Cristina Minardi; Mauro Zaccarelli; Patrizia Rellecati; Paola Santopadre; Fabrizio Soscia; Antonio Scasso; Valerio Tozzi; Maria Ciardi; Gian Carlo Orofino; Pasquale Noto; Antonella d'Arminio Monforte; Andrea Antinori; Albert W Wu
Journal:  J Gen Intern Med       Date:  2004-11       Impact factor: 5.128

7.  A comparison of adherence assessment methods utilized in the United States: perspectives of researchers, HIV-infected children, and their caregivers.

Authors:  Staci Martin; Deborah K Elliott-DeSorbo; Sarah Calabrese; Pamela L Wolters; Gregg Roby; Tara Brennan; Lauren V Wood
Journal:  AIDS Patient Care STDS       Date:  2009-08       Impact factor: 5.078

8.  The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.

Authors:  Viviane D Lima; Richard Harrigan; David R Bangsberg; Robert S Hogg; Robert Gross; Benita Yip; Julio S G Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-15       Impact factor: 3.731

Review 9.  Use of electronic reminder devices to improve adherence to antiretroviral therapy: a systematic review.

Authors:  Julie Wise; Don Operario
Journal:  AIDS Patient Care STDS       Date:  2008-06       Impact factor: 5.078

10.  Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.

Authors:  Gregory P Bisson; Robert Gross; Scarlett Bellamy; Jesse Chittams; Michael Hislop; Leon Regensberg; Ian Frank; Gary Maartens; Jean B Nachega
Journal:  PLoS Med       Date:  2008-05-20       Impact factor: 11.069

View more
  12 in total

1.  Evaluation of adherence to oral antiviral hepatitis B treatment using structured questionnaires.

Authors:  Leesa Giang; Christian P Selinger; Alice Unah Lee
Journal:  World J Hepatol       Date:  2012-02-27

2.  Methodological issues in the assessment of diabetes treatment adherence.

Authors:  Jeffrey S Gonzalez; Havah E Schneider
Journal:  Curr Diab Rep       Date:  2011-12       Impact factor: 4.810

3.  Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings.

Authors:  Kartik K Venkatesh; A K Srikrishnan; Kenneth H Mayer; N Kumarasamy; Sudha Raminani; E Thamburaj; Lakshmi Prasad; Elizabeth W Triche; Suniti Solomon; Steven A Safren
Journal:  AIDS Patient Care STDS       Date:  2010-11-22       Impact factor: 5.078

4.  Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South Africa.

Authors:  Krisda Chaiyachati; Lisa R Hirschhorn; Frank Tanser; Marie-Louise Newell; Till Bärnighausen
Journal:  AIDS Patient Care STDS       Date:  2011-01-26       Impact factor: 5.078

5.  Enhancing HIV medication adherence in India.

Authors:  Deborah Jones; Aman Sharma; Mahendra Kumar; Drenna Waldrop-Valverde; Ritu Nehra; Szonja Vamos; Ryan Cook; Stephen M Weiss
Journal:  J Int Assoc Provid AIDS Care       Date:  2012-05-24

6.  Antiretroviral therapy adherence measurement in non-clinical settings in South India.

Authors:  Nora J Kleinman; Lisa E Manhart; Rani Mohanraj; Shuba Kumar; Lakshmanan Jeyaseelan; Deepa Rao; Jane M Simoni
Journal:  AIDS Care       Date:  2014-08-14

Review 7.  Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention.

Authors:  Paul K Drain; Ashley R Bardon; Jane M Simoni; Tim R Cressey; Pete Anderson; Derin Sevenler; Ayokunle O Olanrewaju; Monica Gandhi; Connie Celum
Journal:  Curr HIV/AIDS Rep       Date:  2020-10       Impact factor: 5.071

8.  Is calculating the standard deviation of tacrolimus blood levels the new gold standard for evaluating non-adherence to medications in transplant recipients?

Authors:  Eyal Shemesh; Richard N Fine
Journal:  Pediatr Transplant       Date:  2010-10-01

9.  Determinants of engagement in HIV treatment and care among Zambians new to antiretroviral therapy.

Authors:  Deborah L Jones; Isaac Zulu; Szonja Vamos; Ryan Cook; Ndashi Chitalu; Stephen M Weiss
Journal:  J Assoc Nurses AIDS Care       Date:  2012-09-23       Impact factor: 1.354

Review 10.  Optimizing adherence to antiretroviral therapy.

Authors:  Seema Sahay; K Srikanth Reddy; Sampada Dhayarkar
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.